NAD+ supplements have become one of the most talked-about categories in the anti-aging market, but the evidence behind them is a patchwork of genuinely interesting findings, underwhelming human trials, and a lot of animal data that hasn’t yet translated to people. NAD+ itself is a molecule involved in hundreds of cellular reactions, and its levels do decline with age. The core promise of supplements like NMN and NR is straightforward: replenish what aging takes away, and health benefits should follow. The reality, as the research stands today, is considerably more complicated.
Why NAD+ Declines With Age
Your body makes NAD+ through several pathways and burns through it constantly. Enzymes called sirtuins use it as fuel to regulate metabolism, DNA repair proteins consume it, and immune cells chew through it during inflammatory responses. The decline isn’t just about making less of it. As you age, certain immune cells ramp up an enzyme called CD38 that actively destroys NAD+ in tissues. Research has shown that pro-inflammatory macrophages accumulate in fat tissue and the liver during aging, expressing high levels of CD38 and breaking down NAD+ faster than the body can replace it.1Nature Metabolism. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages Senescent cells, the “zombie cells” that stop dividing but refuse to die, make this worse by secreting inflammatory signals that trigger even more macrophages to produce CD38.
Separately, the immune system’s own NAD+ production falters with age. Macrophages normally generate NAD+ from tryptophan through what’s called the kynurenine pathway. In aged macrophages, a key step in this conversion gets suppressed, which starves the cells of the NAD+ they need for proper function.2PubMed Central. Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation So aging hits NAD+ from both sides: production falls while consumption rises. This is the biological rationale that launched the entire supplement category.
What Actually Happens When You Swallow an NAD+ Precursor
Most NAD+ supplements contain either nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR). Both are precursors, meaning they’re building blocks the body can theoretically convert into NAD+. But the journey from pill to usable NAD+ is not as direct as the marketing suggests.
A 2025 study using isotope tracers found that only a small fraction of orally taken NMN or NR gets absorbed directly from the small intestine. Most of it is broken down by gut bacteria into nicotinic acid, a simpler form of vitamin B3. That nicotinic acid then gets absorbed and used primarily by the liver to make NAD+ through a roundabout route.3PubMed Central. Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation Even when NMN was given intravenously, it was rapidly broken down into nicotinamide and then converted to nicotinic acid by gut bacteria after being secreted into bile. The researchers concluded that NMN and NR are “indirectly converted to NAD+ via unexpected metabolic pathways.”
This matters for a practical reason: if most of what you swallow ends up as nicotinic acid anyway, the premium you pay for NMN or NR over basic niacin comes into question. There is a specific transporter for NMN in the small intestine, called Slc12a8, which is more active in older mice, suggesting that some direct absorption does occur and may increase with age.4PubMed Central. Slc12a8 is a nicotinamide mononucleotide transporter But the tracer data makes clear that this direct route handles a minority of an oral dose. The gut microbiome, it turns out, is a major gatekeeper of NAD+ precursor metabolism, and individual variation in gut bacteria composition could mean that two people taking the same dose get very different results.
Metabolic Health and Insulin Sensitivity
The most compelling human evidence for NAD+ supplementation so far comes from metabolic studies. A trial published in Science gave NMN (250 mg daily for 10 weeks) to overweight or obese women with prediabetes. Using a gold-standard clamp technique to measure insulin sensitivity, the researchers found that NMN increased muscle insulin sensitivity and improved insulin signaling in skeletal muscle. The placebo group showed no change.5PubMed Central. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
This is one of the few NAD+ supplement trials in humans that used a rigorous clinical endpoint rather than just measuring blood NAD+ levels and calling it a day. The improvement in insulin signaling is meaningful because muscle insulin resistance is a core feature of type 2 diabetes and metabolic syndrome. However, this was a small study in a specific population, so it would be premature to generalize the finding to everyone. The participants were prediabetic women who were overweight or obese, and the effect on people with normal metabolic function is unknown.
Cardiovascular Effects
Arterial stiffness increases with age and is a risk factor for heart disease and stroke. A few trials have looked at whether NAD+ precursors can slow or reverse this process. In a randomized, double-blind trial of NMN supplementation in middle-aged adults, arterial stiffness (measured by pulse wave velocity) showed a trend toward improvement in the NMN group but did not reach statistical significance overall. The more interesting finding was in subgroups: participants with higher BMI or elevated blood glucose showed statistically significant reductions in arterial stiffness compared to placebo.6Scientific Reports. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
A separate pilot trial tested NR combined with exercise in middle-aged and older adults with hypertension. The combination showed a trend toward greater reduction in pulse wave velocity compared to exercise alone.7PubMed Central. Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial “Trend” in both of these studies means the direction was favorable but the sample sizes were too small to rule out chance. Cardiovascular research on NAD+ precursors is still early-stage, and the pattern emerging suggests that benefits may be most apparent in people who already have metabolic risk factors rather than in healthy individuals.
Brain Health in Animal Models
The neurological research on NAD+ is some of the most exciting and also the most frustrating, because nearly all of it comes from mouse models of Alzheimer’s disease. In one study, five months of NR treatment in Alzheimer’s mice increased brain NAD+ levels, reduced neuroinflammation and activation of brain immune cells, decreased cellular senescence, and improved cognitive and synaptic function.8PubMed Central. NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer’s disease via cGAS-STING Another study using a different Alzheimer’s mouse model found that NR reduced DNA damage, neuroinflammation, and loss of hippocampal neurons while restoring synaptic plasticity and cognitive function across multiple behavioral tests.9PubMed Central. NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency
These results are consistent across multiple labs and mouse models, which is encouraging. The proposed mechanism is that NAD+ depletion sits upstream of many Alzheimer’s pathologies, so replenishing it addresses several problems at once. But the gap between rescuing cognitive function in genetically engineered mice and helping humans with Alzheimer’s is enormous. Mouse models of Alzheimer’s have a famously poor track record of predicting what works in people. No human trial has yet demonstrated cognitive improvement from NAD+ supplementation in dementia patients, so while the animal work provides a rationale for human trials, it is not itself evidence that the supplements help human brains.
There is also emerging interest in how NAD+ interacts with circadian rhythms in the brain. NAD+ metabolism and the body’s internal clock regulate each other, and disruptions to this feedback loop may contribute to the sleep problems and cognitive decline seen in various forms of dementia.10PubMed Central. NAD+‒circadian rhythm coupling in dementia Whether supplementing NAD+ precursors can meaningfully restore circadian regulation in aging humans remains an open question, but it adds another dimension to why researchers are interested in NAD+ beyond simple metabolic boosting.
Physical Performance and Exercise
If there is one area where NAD+ supplements have consistently failed to deliver, it is physical performance. Given that NAD+ is essential for mitochondrial energy production, you might expect that boosting it would improve exercise capacity or muscle function. The human data says otherwise. A review in Sports Medicine noted that NR supplementation at 1 gram twice daily for 12 weeks in obese, insulin-resistant adults did not change NAD+ levels in skeletal muscle and had no effect on mitochondrial protein abundance or respiration. A separate trial giving NR at 1 gram daily for three weeks to older men similarly found no increase in mitochondrial respiration or markers of mitochondrial content in muscle.11PubMed Central. NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans
This is a sobering finding and one worth knowing before spending money on supplements for athletic goals. The problem may relate to the absorption issue discussed earlier: if most orally taken NR gets converted to nicotinic acid in the gut and used primarily by the liver, it may never raise NAD+ levels in muscle tissue enough to matter. The disconnect between blood NAD+ levels (which do rise with supplementation) and tissue-specific NAD+ levels (which may not) is a key unresolved question in this field.
Safety and Side Effects
The good news is that both NMN and NR appear well-tolerated in the doses studied so far. A clinical trial found that single oral doses of NMN up to 500 mg produced no significant clinical symptoms, harmful effects, or changes in heart rate, blood pressure, or body temperature.12PubMed Central. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update A longer-duration study found that daily oral NMN at 1,250 mg for four weeks caused no changes beyond normal physiological variation in blood work, urine, or body composition, and no serious adverse events were reported.13Scientific Reports. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women
For NR, a randomized placebo-controlled trial testing doses from 100 mg to 1,000 mg found that adverse events were similar across all groups including placebo. The mild events possibly related to NR included occasional nausea, muscle soreness, and leg pain, all of which resolved by the end of the study. No flushing was reported, which distinguishes NR from regular niacin (vitamin B3), which is infamous for causing uncomfortable skin flushing.14Scientific Reports. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
These safety profiles are reassuring but come with a major caveat: the longest trials we have lasted only weeks to a few months. NAD+ supplements are marketed for long-term daily use, sometimes for years. We have essentially no controlled human data on what happens over that timeframe.
The Cancer Question
One concern that comes up repeatedly in scientific discussions but rarely in supplement marketing is whether raising NAD+ could fuel cancer growth. Cancer cells are metabolically hyperactive and have high energy demands. Sirtuins, the enzymes that NAD+ powers, have complex roles in cancer biology, sometimes acting as tumor suppressors and sometimes promoting tumor survival depending on the context. A review in Aging Cell flagged that further research is needed into whether elevating NAD+ levels or boosting sirtuin activity could increase the potential for cancer or other age-related diseases, given the high energy requirements of certain conditions like cancer.15PubMed Central. Nicotinamide adenine dinucleotide and the sirtuins caution: Pro-cancer functions
This does not mean NAD+ supplements cause cancer. No human study has found an increased cancer rate with supplementation. But the theoretical concern is biologically plausible, and the absence of evidence is not the same as evidence of absence, especially when the longest human trials lasted only a few months. If you have a personal or family history of cancer, this is worth discussing with your oncologist before starting long-term supplementation.
Skin, Fertility, and Other Emerging Areas
NAD+ research has branched into several areas that don’t make headlines as often but may matter to specific groups of people.
In skin aging, laboratory work on human fibroblasts has shown that exogenous NAD+ can protect against damage from both UV exposure and normal intrinsic aging.16PubMed Central. Novel Approach to Skin Anti-Aging: Boosting Pharmacological Effects of Exogenous Nicotinamide Adenine Dinucleotide (NAD+) by Synergistic Inhibition of CD38 Expression NMN specifically has been shown in cell and animal studies to block UV-induced collagen breakdown by reducing oxidative stress and activating pathways that promote collagen synthesis.17PubMed. β-Nicotinamide mononucleotide blocks UVB-induced collagen reduction via regulation of ROS/MAPK/AP-1 and stimulation of mitochondrial proline biosynthesis The cosmetics industry has taken notice, and topical NAD+ and NMN products are appearing on the market. Whether oral supplements improve skin appearance in humans is untested in rigorous trials.
In reproductive health, animal research has shown that NMN can rejuvenate oocyte quality in aged mice and restore fertility.18PubMed Central. NAD+ Repletion Rescues Female Fertility during Reproductive Aging Across multiple studies, supplementation with NAD+ precursors has protected aging oocytes from meiotic errors, reduced chromosomal abnormalities, and improved pregnancy rates and live births in aged mice.19Biochemistry and Biophysics Reports. Supplementation with NAD+ and its precursors: A rescue of female reproductive diseases For women dealing with age-related fertility decline, this is tantalizing, but as with the brain research, the leap from mice to humans has not been made. A review noted that while exogenous NAD+ precursors have been shown to improve ovarian aging in animals, human data confirming these effects is still absent.20Biology of Reproduction. Is NAD+ a key factor in ovarian aging and dysfunction? Insights and uncertainties from current research
IV Delivery and Alternative Routes
NAD+ IV drips have become a fixture in boutique wellness clinics, often priced at several hundred dollars per session. The rationale is that bypassing the gut avoids the microbial degradation that limits oral absorption. But the science here is thin. A clinical review noted that the metabolism of intravenously infused NAD+ is currently unclear, though it is likely cleaved into nicotinamide and other components by the liver, much as it is when taken orally. It’s also possible that CD38-expressing immune cells in the blood break down infused NAD+ in plasma.21PubMed Central. Clinical Evidence for Targeting NAD Therapeutically
A pilot study comparing IV NR, IV NAD+, and oral NR found that IV NR produced the most robust increases in blood NAD+ concentration, with peak levels rising by about 21% relative to baseline and outperforming both IV NAD+ and oral NR at the three-hour mark.22medRxiv. Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults That’s an interesting finding, but it’s from a single small pilot study and hasn’t been linked to any downstream health outcome. Higher blood NAD+ at three hours is a pharmacokinetic observation, not proof of clinical benefit. Until larger trials connect a specific delivery method to a health outcome that matters, the choice between oral and IV delivery is largely a matter of convenience and cost.
Combination Approaches and CD38 Inhibition
One of the more intellectually honest conversations in the NAD+ field is about whether precursor supplements alone are sufficient, or whether you also need to address the enzymes that are degrading NAD+ in the first place. As discussed earlier, CD38 is a major driver of NAD+ consumption in aging tissues. If you keep pouring precursors in without slowing the drain, the effect may be limited.
This has led to interest in combining NAD+ precursors with compounds that inhibit CD38 or activate sirtuins. A framework has been proposed around pairing NMN or NR with geroprotective compounds like flavonoids that may inhibit CD38 or support sirtuin activity, potentially enhancing the efficacy of precursor supplementation alone.23PubMed Central. Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan Some supplement companies have started selling formulations that combine NMN with compounds like quercetin and resveratrol based on this rationale. In vitro testing of one such formulation reported several-fold increases in sirtuin pathway activation and sustained intracellular NAD+ maintenance compared to NMN alone.24International Journal of Public Health and Medical Research. BCLC™ NAD⁺ Supplement System Targeting SIRT1: A Time-Sequential Biphasic NMN-Resveratrol-Quercetin Formulation with Supporting Clinical and Pharmacological Evidence Cell culture results like these are interesting starting points, but they’re far from proof that combination supplements work better in living humans. The gap between what happens in a petri dish and what happens in a person is one of the most consistently underestimated distances in biomedical science.
Measuring Your Own NAD+ Levels
A growing number of companies now offer at-home NAD+ testing through dried blood spot kits, letting consumers track whether their supplements are actually raising NAD+ levels. Research has validated that dried blood spot assays can reliably detect changes in whole blood NAD+ concentration, including dose-dependent increases from NMN supplementation.25PubMed Central. Fingerstick blood assay maps real‐world NAD+ disparity across gender and age A population-level study using this approach confirmed that supplementation with NAD+ precursors does increase whole blood NAD+ levels and that the assay can detect the response.26Genetics in Medicine Open. Understanding the measurement of nicotinamide adenine dinucleotide (NAD+) from dried blood spots through a population study
The relationship between age and NAD+ levels, however, is not as clean as you might expect. While the general trend is downward with age, there was not a direct correlation between age and whole blood NAD+ concentration in the population data. This suggests that factors beyond simply getting older, such as diet, inflammation, physical activity, and individual variation in CD38 activity or gut microbiome composition, play significant roles in determining your NAD+ status. Knowing your blood NAD+ level tells you one thing: whether the supplement is getting absorbed and raising circulating levels. What it does not tell you is whether that increase is reaching the specific tissues where it would make a difference, which, as the skeletal muscle data showed, is not guaranteed.
The Sirtuin Connection
Much of the theoretical case for NAD+ supplements rests on sirtuins, a family of enzymes that use NAD+ as a cofactor and are involved in regulating mitochondrial function, DNA repair, and metabolic responses. Sirtuins act as sensors that adjust cellular behavior based on nutrient availability. When NAD+ is abundant, sirtuins are more active; when it drops, their activity declines.27PubMed Central. Mitochondrial metabolism, sirtuins, and aging The logic of NAD+ supplementation is essentially: more NAD+ means more sirtuin activity, which means better cellular maintenance.
The catch is that sirtuin biology is not straightforwardly beneficial. Some sirtuins have been linked to tumor promotion in certain contexts, which is part of the cancer concern discussed earlier. And sirtuin activation does not automatically translate to better health outcomes in humans. Caloric restriction, which strongly activates sirtuins through naturally raising the NAD+-to-NADH ratio, does extend lifespan in many animal models, but replicating the benefits of caloric restriction through a pill remains an unproven concept. The supplements may boost one input to the sirtuin system, but whether that’s sufficient to meaningfully change the output in a free-living human eating a normal diet is a question the field hasn’t answered.
Regulatory Uncertainty
The legal status of NAD+ precursors, particularly NMN, has been in flux. In the United States, NMN’s classification has been disputed: the FDA at one point questioned whether NMN could be sold as a dietary supplement given that it was being investigated as a drug. Meanwhile, the broader regulatory landscape for novel dietary ingredients in both the U.S. and European markets involves ongoing legal interpretation about what qualifies as a supplement versus a pharmaceutical, with authorities increasingly signaling interest in international cooperation on safety assessments.28Taylor & Francis Online / PubMed Central. The Regulatory Challenges of Placing Dietary Ingredients on the European and US Market For consumers, the practical upshot is that the NMN you buy today may not be manufactured under the same standards as a pharmaceutical, and product quality can vary between brands. Third-party testing certificates and established manufacturers offer some reassurance, but the regulatory situation remains unsettled.